Gliknik gliknik.com


Public list: Pharma Startups (6570) Cancer Therapeutics (1180)

Gliknik is a privately held biopharmaceutical company creating new therapies for patients with cancer and immune disorders. Gliknik specializes in the modulation of the immune system to fight disease. The Gliknik clinical compound is the immune modulator GL-0817 for cancer, which is in a randomized, blinded, placebo-controlled study in the prevention of recurrence of high-risk oral cavity cancer.

Gliknik is a privately held biopharmaceutical company creating new therapies for patients with cancer and immune disorders. Gliknik specializes in the modulation of the immune system to fight disease. The Gliknik clinical compound is the immune modul...Show all

Company (Alive / Active)

Phone: 410-685-4259

Fax:

801 W. Baltimore Street
Suite 501A
Baltimore, 21201
Maryland, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Gliknik $45M Feb 19, 2019
Transgenomic $92.3M Oct 5, 2005
Biocolor $0M Nov 10, 2019
See all 14 competitors

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Gliknik Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 6 investors

Board Members

Competitors

Company Status Description Investors
See all 14 competitors

Patents

Title Application Date Patent Date Status
(Patent / Application)
Immunoglobulin constant region fc receptor binding agents Apr 10, 2017 Mar 27, 2018 Patent
Molecules with antigen binding and polyvalent fc gamma receptor binding activity Aug 20, 2013 Jun 20, 2017 Patent
Immunoglobulin constant region fc receptor binding agents Mar 20, 2014 Dec 06, 2016 Patent
Immunoglobulin constant region fc receptor binding agents Sep 20, 2013 Dec 06, 2016 Patent
Immunoglobulin constant region fc receptor binding agents May 30, 2008 Mar 25, 2014 Patent
See all 12 patents